Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seamus Kent

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Clinical Pharmacology and Therapeutics|February 17, 2025
Planning Post-Launch Evidence Generation: Lessons From France, England and SpainSeamus Kent, Francois Meyer, Alina Pavel, et al.
The Lancet. Public Health|December 19, 2017
Hospital costs in relation to body-mass index in 1·1 million women in England: a prospective cohort studySeamus Kent, Jane Green, Gillian Reeves, et al.
Hypertension (Dallas, Tex. : 1979)|March 1, 2021
Impact of the 2003 to 2018 Population Salt Intake Reduction Program in England: A Modeling StudySergi Alonso, Monique Tan, Changqiong Wang, et al.
International Journal of Obesity (2005)|December 21, 2018
Body mass index and use and costs of primary care services among women aged 55-79 years in England: a cohort and linked data studySeamus Kent, Susan A Jebb, Alastair Gray, et al.
Pharmacoeconomics|December 18, 2020
Common Problems, Common Data Model Solutions: Evidence Generation for Health Technology AssessmentSeamus Kent, Edward Burn, Dalia Dawoud, et al.
Circulation. Cardiovascular Quality and Outcomes|July 14, 2016
Effects of Vascular and Nonvascular Adverse Events and of Extended-Release Niacin With Laropiprant on Health and Healthcare CostsSeamus Kent, Richard Haynes, Jemma C Hopewell, et al.
BMJ Open|December 7, 2024
Evaluating transportability of overall survival estimates from US to UK populations receiving first-line treatment for advanced non-small cell lung cancer: a retrospective cohort studySeamus Kent, Philani Mpofu, Stephen Duffield, et al.
Journal of Comparative Effectiveness Research|June 9, 2022
Application of quantitative bias analysis for unmeasured confounding in cost-effectiveness modellingThomas P Leahy, Stephen Duffield, Seamus Kent, et al.
BMJ Open|October 17, 2023
Evaluation of US oncology electronic health record real-world data to reduce uncertainty in health technology appraisals: a retrospective cohort studyPhilani Mpofu, Seamus Kent, Páll Jónsson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 7, 2021
Cost-Effectiveness of Dopamine Agonists and Monoamine Oxidase B Inhibitors in Early Parkinson's DiseaseEmma McIntosh, Seamus Kent, Alastair Gray, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Clinical Pharmacology and Therapeutics|February 17, 2025
Planning Post-Launch Evidence Generation: Lessons From France, England and SpainSeamus Kent, Francois Meyer, Alina Pavel, et al.
The Lancet. Public Health|December 19, 2017
Hospital costs in relation to body-mass index in 1·1 million women in England: a prospective cohort studySeamus Kent, Jane Green, Gillian Reeves, et al.
Hypertension (Dallas, Tex. : 1979)|March 1, 2021
Impact of the 2003 to 2018 Population Salt Intake Reduction Program in England: A Modeling StudySergi Alonso, Monique Tan, Changqiong Wang, et al.
International Journal of Obesity (2005)|December 21, 2018
Body mass index and use and costs of primary care services among women aged 55-79 years in England: a cohort and linked data studySeamus Kent, Susan A Jebb, Alastair Gray, et al.
Pharmacoeconomics|December 18, 2020
Common Problems, Common Data Model Solutions: Evidence Generation for Health Technology AssessmentSeamus Kent, Edward Burn, Dalia Dawoud, et al.
Circulation. Cardiovascular Quality and Outcomes|July 14, 2016
Effects of Vascular and Nonvascular Adverse Events and of Extended-Release Niacin With Laropiprant on Health and Healthcare CostsSeamus Kent, Richard Haynes, Jemma C Hopewell, et al.
BMJ Open|December 7, 2024
Evaluating transportability of overall survival estimates from US to UK populations receiving first-line treatment for advanced non-small cell lung cancer: a retrospective cohort studySeamus Kent, Philani Mpofu, Stephen Duffield, et al.
Journal of Comparative Effectiveness Research|June 9, 2022
Application of quantitative bias analysis for unmeasured confounding in cost-effectiveness modellingThomas P Leahy, Stephen Duffield, Seamus Kent, et al.
BMJ Open|October 17, 2023
Evaluation of US oncology electronic health record real-world data to reduce uncertainty in health technology appraisals: a retrospective cohort studyPhilani Mpofu, Seamus Kent, Páll Jónsson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 7, 2021
Cost-Effectiveness of Dopamine Agonists and Monoamine Oxidase B Inhibitors in Early Parkinson's DiseaseEmma McIntosh, Seamus Kent, Alastair Gray, et al.
Pageof 4